Javier Vaquero

8PUBLICATIONS
42CO-AUTHORS
ChemotherapyMolecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 27, 2025
Aurora kinase B at the nexus of cholesterol metabolism and therapy response in cholangiocarcinoma.

Elisa Lozano, Javier Vaquero

|Aug 17, 2025
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts.

Josep Amengual, Ester Gonzalez-Sanchez, Mariana Yáñez-Bartolome

|Sep 17, 2024
Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progression.

Josep Amengual, Ania Alay, Javier Vaquero

|Jun 14, 2024
The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche.

Ester Gonzalez-Sanchez, Javier Vaquero, Daniel Caballero-Diaz

|Jan 16, 2024
Enhancing the opportunities for cholangiocarcinoma precision therapy.

Reka Toth, Paul J Brindley, Javier Vaquero

|Feb 09, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance.

Diego F Calvisi, Luke Boulter, Javier Vaquero

Pageof 2

Frequent Collaborators

4 joint publications

Isabel Fabregat

3 joint publications

Laura Fouassier

2 joint publications

Diego F Calvisi

2 joint publications

Ania Alay